![Mohammad A. El-Kalay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mohammad A. El-Kalay was the founder who founded EyeCyte, Inc. in 2008 and served as President & Chief Executive Officer in 2010.
He also held former positions as Director-Product Development at Applied Immune Sciences, Inc., Systemix, Inc., and Osiris Corp.
He was Vice President-Process Development at StemCells, Inc., Vice President-Technical Operations at Sangamo Therapeutics, Inc., Vice President-Product Development at Morphogenesis, Inc., Vice President-Research & Development at MicroIslet, Inc., and Senior Vice President-Research & Development at Telos Pharmaceuticals LLC.
Dr. El-Kalay received his undergraduate, graduate, and doctorate degrees from the University of Strathclyde.
| Sociétés | Poste | Fin |
|---|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology Researches and develops stem cell therapeutics | Corporate Officer/Principal | - |
| SANGAMO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Corporate Officer/Principal | - |
Applied Immune Sciences, Inc.
 Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Surgical & medical instruments | Corporate Officer/Principal | - |
| OSIRIS CORPORATION | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 10 |
|---|---|
Applied Immune Sciences, Inc.
Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Surgical & medical instruments | Health Technology |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology Researches and develops stem cell therapeutics | Health Technology |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Health Services |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
TuHURA Biosciences, Inc. (Old)
 TuHURA Biosciences, Inc. (Old) BiotechnologyHealth Technology Develops cancer vaccines and tumor microenvironment modulators | Health Technology |
MicroIslet, Inc.
 MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical research for the treatment of diabetes | Commercial Services |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Osiris Corp.
 Osiris Corp. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and markets industrial and construction equipment | Producer Manufacturing |
EyeCyte, Inc.
 EyeCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of retinal disease | Health Technology |
Telos Pharmaceuticals LLC |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
